Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ARK Levetiracetam II Assay

K-Number: K232522 · 2024-02-27

Decision Date2024-02-27
Product CodeORI
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

ARK Levetiracetam II Assay is the device name listed in this FDA 510(k) record. The listed applicant is Ark Diagnostics, Inc.. It received FDA 510(k) clearance on 2024-02-27 under 510(k) number K232522. The device is classified under product code ORI. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ARK Levetiracetam II Assay?

ARK Levetiracetam II Assay is a medical device that received FDA 510(k) clearance on 2024-02-27. The listed applicant is Ark Diagnostics, Inc.. The 510(k) number is K232522.

When did ARK Levetiracetam II Assay receive FDA 510(k) clearance?

ARK Levetiracetam II Assay received FDA 510(k) clearance on 2024-02-27, under 510(k) number K232522.

Who is the listed applicant for ARK Levetiracetam II Assay?

The FDA 510(k) record lists Ark Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ARK Levetiracetam II Assay?

The FDA product code for ARK Levetiracetam II Assay is ORI.

Other records listing Ark Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 10 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.